Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Farhat MM"'
Autor:
Brakta C; Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France., Tabet AC; Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, EU, France., Puel M; Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France., Pacault M; Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, EU, France., Stolzenberg MC; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, UMR 1163, Imagine Institute, INSERM, Paris, EU, France.; Inserm U1163, Imagine Institute, University of Paris Cité, Paris, Paris, EU, France., Goudet C; Pediatric Hematology Department, Timone Enfant, Assistance Publique Hôpitaux de Marseille (AP-HM), Marseille, EU, France., Merger M; Department of Internal Medicine and Clinical Immunology, University of Lille, Lille, EU, France., Reumaux H; Pediatric Rheumatology Unit, Jeanne de Flandre Hospital, University of Lille, Lille, EU, France., Lambert N; Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France., Alioua N; Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France., Malan V; Inserm U1163, Imagine Institute, University of Paris Cité, Paris, Paris, EU, France.; Laboratory of Genomic Medicine for Rare Diseases, Necker Hospital for Sick Children, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France., Hanein S; Bioinformatic Platform, Institute of Genetic Diseases, Université Paris-Cité and Structure Fédérative de Recherche Necker, INSERM UMR1163, Imagine, Paris, EU, France., Dupin-Deguine D; Medical Genetics Department, University of Toulouse, CHU Purpan, Toulouse, EU, France.; Otoneurosurgery and Pediatric ENT Department, University of Toulouse, CHU Purpan, Toulouse, EU, France., Treiner E; Faculty of Medicine, University Toulouse III Paul Sabatier, Toulouse, France.; Laboratory of Immunology, University Hospital of Toulouse, Toulouse, France.; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Inserm UMR1291, Toulouse, EU, France., Lefèvre G; Institute for Translational Research in Inflammation (INFINITE), Inserm U1286, University of Lille, Lille, EU, France.; Laboratory of Immunology, University of Lille, Lille, EU, France., Farhat MM; Department of Internal Medicine and Clinical Immunology, University of Lille, Lille, EU, France., Luca LE; Department of Internal Medicine, Infectious and Tropical Diseases, University Hospital Center of Poitiers, Poitiers, EU, France., Hureaux M; Department of Genetics, Georges-Pompidou European Hospital, AP-HP, Paris, EU, France.; Reference Center for Hereditary Kidney Diseases in Children and Adults (MARHEA), University of Paris Cité, Paris, EU, France., Li H; Inserm U1163, Imagine Institute, University of Paris Cité, Paris, Paris, EU, France.; Laboratory of Human Genetics of Infectious Diseases, Necker Hospital for Sick Children, Necker Branch, Inserm U1163, Paris, EU, France., Chelloug N; Medical Genetics Department, University of Toulouse, CHU Purpan, Toulouse, EU, France., Dehak R; Department of Pediatrics, Calais Hospital, Calais, EU, France., Boussion S; Clinical Genetics Department, University of Lille, Lille, EU, France., Ouachée-Chardin M; Department of Pediatric Hematology, IHOPe, Hospices Civils de Lyon, Lyon, EU, France., Schleinitz N; Department of Internal Medicine La Timone, Aix-Marseille University, Assistance Publique - AP-HM, Marseille, EU, France., Abou Chahla W; Department of Pediatric Hematology, Jeanne de Flandre Hospital, University of Lille, Lille, EU, France., Barlogis V; Pediatric Hematology Department, Timone Enfant, Assistance Publique Hôpitaux de Marseille (AP-HM), Marseille, EU, France., Vély F; Aix Marseille Université, CNRS, Inserm, Centre d'Immunologie de Marseille-Luminy, Marseille, EU, France.; Departement of Immunology, Assistance Publique Des Hôpitaux de Marseille, Hôpital de La Timone, Marseille Immunopole, Marseille, EU, France., Oksenhendler E; Clinical Immunology Department, Saint-Louis Hospital, Paris-Diderot University, Paris, EU, France., Quartier P; Pediatric Immunology-Hematology and Rheumatology Unit, Necker-Enfants Malades University Hospital, AP-HP, Paris, EU, France.; Université Paris-Cité, Paris, EU, France., Pasquet M; Department of Pediatric Hematology and Immunology, Children's Hospital, University Hospital, Toulouse, EU, France., Suarez F; Université Paris-Cité, Paris, EU, France.; Department of Clinical Hematology, Necker Hospital for Sick Children, AP-HP, Paris, EU, France.; Centre de Référence Des Déficits Immunitaires Héréditaires (CEREDIH), Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France., Bustamante J; Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France.; Laboratory of Human Genetics of Infectious Diseases, Necker Hospital for Sick Children, Necker Branch, Inserm U1163, Paris, EU, France.; Université Paris-Cité, Paris, EU, France.; St.Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller University, Rockefeller Branch, New York, NY, USA., Neven B; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, UMR 1163, Imagine Institute, INSERM, Paris, EU, France.; Inserm U1163, Imagine Institute, University of Paris Cité, Paris, Paris, EU, France.; Pediatric Immunology-Hematology and Rheumatology Unit, Necker-Enfants Malades University Hospital, AP-HP, Paris, EU, France.; Université Paris-Cité, Paris, EU, France., Picard C; Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France.; Université Paris-Cité, Paris, EU, France.; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Inserm U1163, Imagine Institute, Paris, EU, France.; Centre de Référence Des Déficits Immunitaires Héréditaires (CEREDIH), Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France., Rieux-Laucat F; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, UMR 1163, Imagine Institute, INSERM, Paris, EU, France.; Inserm U1163, Imagine Institute, University of Paris Cité, Paris, Paris, EU, France., Lévy J; Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, EU, France., Rosain J; Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France. jeremie.rosain@institutimagine.org.; Laboratory of Human Genetics of Infectious Diseases, Necker Hospital for Sick Children, Necker Branch, Inserm U1163, Paris, EU, France. jeremie.rosain@institutimagine.org.; Université Paris-Cité, Paris, EU, France. jeremie.rosain@institutimagine.org.; St.Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller University, Rockefeller Branch, New York, NY, USA. jeremie.rosain@institutimagine.org.
Publikováno v:
Journal of clinical immunology [J Clin Immunol] 2024 Nov 23; Vol. 45 (1), pp. 46. Date of Electronic Publication: 2024 Nov 23.
Autor:
Talarico R; Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy., Marinello D; Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy., Palla I; Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy., Cannizzo S; Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy., Galetti I; FESCA Federation of European Scleroderma Associations, Saint Maur, Belgium.; GILS Gruppo Italiano Lotta alla Sclerodermia, Milan, Italy., Farrington S; FESCA Federation of European Scleroderma Associations, Saint Maur, Belgium., Aguilera S; SRUK Scleroderma & Raynaud's UK, London, UK.; Spanish Association for Antiphospholipid Syndrome (SAF España), Elche, Spain., Andersen J; Lupus Europe, Brussels, Belgium., Ceccatelli E; Scuola Superiore Sant'Anna, Pisa, Italy., Cornet A; Lupus Europe, Brussels, Belgium., Cutillas G; AEE Asociación Española de Escleredermia (Spanish Scleroderma Association), Madrid, Spain., Esteves M; Portuguese Association of Scleroderma patients, Moncao, Portugal., Frank C; Flemish Association for Hereditary Connective Tissue Disorders (Bindweefsel.be), Koersel, Belgium., Leite C; University of Minho, Braga, Portugal., Niehaus G; FESCA Federation of European Scleroderma Associations, Munich, Germany., Perez Gomez E; AEE Asociación Española de Escleredermia (Spanish Scleroderma Association), Madrid, Spain., Polfliet K; Sclero'ken vzw Belgische vereniging Sclerodermie, Sinaai, Belgium., Sandulescu S; Romanian Association of Patient with Scleroderma, Bucarest, Romania., Schriemer R; Nationale vereniging voor mensen met lupus, APS, sclerodermie en MCTD (Dutch Association for people living with lupus, APS, Scleroderma and MCTD), Utrecht, The Netherlands., Barsotti S; Rheumatology Outpatient Clinic and Internal Medicine, Livorno Hospital, Livorno, Italy., Bellando-Randone S; Division of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, AOU Careggi, Florence, Italy., Beretta L; Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy., Bernardino V; Unidade de Doenças Autoimunes, Hospital Curry Cabral, Centro Hospitalar Universitário Lisboa Central, Unidade Local de Saúde S. José, Centro Clínico Académico de Lisboa, Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal., Boleto G; Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal.; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Bombardieri S; University of Pisa, Pisa, Italy., Burmester G; Department of Rheumatology and Clinical Immunology, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany., Cavazzana I; Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili and University of Brescia, Brescia, Italy., Codullo V; Department of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy., Cutolo M; Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS Polyclinic Hospital San Martino, University of Genoa, Genoa, Italy., Dalm V; Department of Internal Medicine and Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands., Damian L; Department of Rheumatology, County Emergency Clinical Hospital Cluj-Napoca, Centre for Rare Musculoskeletal Autoimmune and Autoinflammatory Diseases, Cluj-Napoca, Romania., Della Rossa A; Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy., Doria A; Rheumatology Unit, Department of Medicine, University of Padova, Padua, Italy., Farhat MM; Department of Internal Medicine and Clinical immunology, Referral Centre for Rare Systemic Auto-immune Diseases North and North-West Mediterranean and Guadeloupe, University of Lille, Lille, France.; Inserm, CHU Lille, U1286 - INFINITE, University of Lille, Lille, France., Fonseca JE; Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal.; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Hachulla E; Department of Internal Medicine and Clinical immunology, Referral Centre for Rare Systemic Auto-immune Diseases North and North-West Mediterranean and Guadeloupe, University of Lille, Lille, France.; Inserm, CHU Lille, U1286 - INFINITE, University of Lille, Lille, France., Houssiau F; Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Grazia Lazzaroni M; Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili and University of Brescia, Brescia, Italy., Limper M; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Lorenzoni V; Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy., Montecucco C; Department of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy., Mosca M; Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy., Mouthon L; Service de Médecine Interne, Hôpital Cochin, Centre de Référence Maladies Systémiques Autoimmunes et Autoinflammatoires Rares d'Ile de France, de l'Est et de l'Ouest, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France., Müeller-Ladner U; Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus Liebig University of Giessen, Bad Nauheim, Germany., Pha M; Service de Médecine Interne 2, centre de réference maladies rares d'Ile-de-France, Centre et Martinique, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, Paris, France., Ponte C; Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal.; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Spierings J; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Sulli A; Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS Polyclinic Hospital San Martino, University of Genoa, Genoa, Italy., Taulaigo AV; Unidade de Doenças Autoimunes, Hospital Curry Cabral, Centro Hospitalar Universitário Lisboa Central, Unidade Local de Saúde S. José, Centro Clínico Académico de Lisboa, Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal., Ticciati S; Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy., Tincani A; Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili and University of Brescia, Brescia, Italy., Toplak N; Department of Allergology, Rheumatology and Clinical Immunology, University Children's Hospital Ljubljana, University Medical Centre Ljubljana, Ljubljana, Slovenia.; Department of Pediatrics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Trieste L; Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy., van Hagen PM; Department of Internal Medicine, Division of Allergy & Clinical Immunology and Department of Immunology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., van Laar J; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Vanthuyne M; Department of Rheumatology, Cliniques Universitaires Saint-Luc, Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Université Catholique de Louvain, Brussels, Belgium., Vigone B; Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy., de Vries-Bouwstra JK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands., Zen M; Rheumatology Unit, Department of Medicine, University of Padova, Padua, Italy., Turchetti G; Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy., Smith V; Department of Rheumatology, Ghent University Hospital Department of Internal Medicine, Ghent, Belgium.; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Centre (IRC), Ghent, Belgium., Matucci Cerinic M; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.
Publikováno v:
Journal of scleroderma and related disorders [J Scleroderma Relat Disord] 2024 Oct 07, pp. 23971983241269109. Date of Electronic Publication: 2024 Oct 07.
Autor:
Chikhoune L; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France. Electronic address: Liticia.chikhoune@chu-lille.fr., Morell Dubois S; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France., Ledoult E; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France; U1286-INFINITE-Institute for Translational Research in Inflammation, université de Lille, 59000 Lille, France; Inserm, 59000 Lille, France., Launay D; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France; U1286-INFINITE-Institute for Translational Research in Inflammation, université de Lille, 59000 Lille, France; Inserm, 59000 Lille, France., Hachulla E; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France; U1286-INFINITE-Institute for Translational Research in Inflammation, université de Lille, 59000 Lille, France; Inserm, 59000 Lille, France., Lambert M; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France., Yelnik C; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France., Maillard H; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France., Terriou L; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France., Nicolas A; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France., Cebrian R; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France., Despre M; Service de médecine interne, CHU d'Angers, 49100 Angers, France., Sobanski V; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France; U1286-INFINITE-Institute for Translational Research in Inflammation, université de Lille, 59000 Lille, France; Inserm, 59000 Lille, France., Farhat MM; Service de médecine interne et immunologie clinique, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte Nord, Nord-Ouest, Méditerranée et Guadeloupe, CHU de Lille, 59000 Lille, France; U1286-INFINITE-Institute for Translational Research in Inflammation, université de Lille, 59000 Lille, France; Inserm, 59000 Lille, France.
Publikováno v:
La Revue de medecine interne [Rev Med Interne] 2024 Aug; Vol. 45 (8), pp. 468-473. Date of Electronic Publication: 2024 Jun 06.
Autor:
Farhat MM; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Inserm, Lille, France.; Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France., Guerreschi P; Plastic Surgery Department, University Hospital of Lille, Lille, France.; Competence Center for Clefts and CranioFacial Malformations, Lille, France., Morell-Dubois S; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Inserm, Lille, France.; Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France., Deken V; Univ. Lille, CHU Lille, EA2694-Santé publique: épidémiologie et qualité des soins, Lille, France., Labreuche J; Univ. Lille, CHU Lille, EA2694-Santé publique: épidémiologie et qualité des soins, Lille, France., Sanges S; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Inserm, Lille, France.; Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France., Sobanski V; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Inserm, Lille, France.; Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France., Hachulla E; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Inserm, Lille, France.; Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France., Cottencin O; INSERM U-1172. Univ Lille. LiNC. PSY team, CHU Lille Department of Psychiatry and Addiction Medicine, Lille, France., Launay D; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Inserm, Lille, France.; Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France.
Publikováno v:
Journal of scleroderma and related disorders [J Scleroderma Relat Disord] 2024 Jun; Vol. 9 (2), pp. 124-133. Date of Electronic Publication: 2024 Feb 27.
Autor:
Stuchfield-Denby E; Médecine interne, CHU Gabriel Montpied, Clermont-Ferrand, France. Electronic address: emily.stuchfield-denby@doctorant.uca.fr., De Sainte Marie B; Médecine interne, Hôpital de la Timone, AP-HM, Aix-Marseille Université, Marseille, France., Hie M; Medecine interne, Hôpital Pitié-Salpêtrière, Paris, France., Hatchuel Y; Pédiatrie, Hôpital Pierre Zobda-Quitman, CHU de Martinique, Fort de France, Martinique., Gerber A; Médecine interne, CHU Nord Félix Guyon, Saint-Denis, La Réunion, France., Bencheikh S; Médecine interne, Centre Hospitalier de Perpignan, Perpignan, France., Pugnet G; Service de Médecine Interne et Immunologie Clinique, CHU Rangueil, Toulouse, France., Groh M; National Reference Center for Hypereosinophilic Syndromes (CEREO), Department of Internal Medicine, Foch Hospital, Suresnes, France, Univ. Lille, INSERM U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France., Farhat MM; University Lille, Inserm, CHU de Lille, Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France., Urbina D; Service de médecine infantile, Hôpital Timone Enfants, Marseille, France., Ebbo M; Médecine interne, Hôpital de la Timone, AP-HM, Aix-Marseille Université, Marseille, France., Schleinitz N; Médecine interne, Hôpital de la Timone, AP-HM, Aix-Marseille Université, Marseille, France.
Publikováno v:
Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2024 Feb; Vol. 64, pp. 152278. Date of Electronic Publication: 2023 Nov 11.
Autor:
Antoine P; University Lille, Inserm, CHU de Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Rférence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France., Morell-Dubois S; University Lille, Inserm, CHU de Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Rférence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France., Maillard H; University Lille, Inserm, CHU de Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Rférence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France., Wojtasik G; University Lille, Inserm, CHU de Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Rférence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France., Sanges S; University Lille, Inserm, CHU de Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Rférence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France., Launay D; University Lille, Inserm, CHU de Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Rférence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France., Sobanski V; University Lille, Inserm, CHU de Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Rférence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France., Saraux A; EA2216, ESPRI 29, IFR148, Département de Rhumatologie et de Pédiatrie, Hôpital de la Cavale-Blanche, Brest, and Université de Bretagne occidentale, Brest, France., Devauchelle V; EA2216, ESPRI 29, IFR148, Département de Rhumatologie et de Pédiatrie, Hôpital de la Cavale-Blanche, Brest, and Université de Bretagne occidentale, Brest, France., Hachulla E; University Lille, Inserm, CHU de Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Rférence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France., Farhat MM; University Lille, Inserm, CHU de Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Rférence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France. meryem.farhat@chu-lille.fr.
Publikováno v:
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2023 Dec; Vol. 41 (12), pp. 2379-2388. Date of Electronic Publication: 2023 Jun 30.
Autor:
Speca S; University of Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France., Farhat MM; University of Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Département de Médecine Interne Et Immunologie Clinique, Centre de Référence Des Maladies Auto-Immunes Systémiques Rares du Nord Et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France., Jendoubi M; University of Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France., Guerrier T; University of Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France., Sanges S; University of Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Département de Médecine Interne Et Immunologie Clinique, Centre de Référence Des Maladies Auto-Immunes Systémiques Rares du Nord Et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France., Staumont-Sallé D; University of Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Service de Dermatologie, CHU Lille, Lille, France., Hachulla E; University of Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Département de Médecine Interne Et Immunologie Clinique, Centre de Référence Des Maladies Auto-Immunes Systémiques Rares du Nord Et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France., Dubucquoi S; University of Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Institut d'Immunologie, Centre de Biologie Pathologie, CHU Lille, Lille, France., Sobanski V; University of Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Département de Médecine Interne Et Immunologie Clinique, Centre de Référence Des Maladies Auto-Immunes Systémiques Rares du Nord Et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France., Collet A; University of Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Institut d'Immunologie, Centre de Biologie Pathologie, CHU Lille, Lille, France., Launay D; University of Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France. david.launay@univ-lille.fr.; Département de Médecine Interne Et Immunologie Clinique, Centre de Référence Des Maladies Auto-Immunes Systémiques Rares du Nord Et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France. david.launay@univ-lille.fr.
Publikováno v:
Scientific reports [Sci Rep] 2023 Sep 12; Vol. 13 (1), pp. 15102. Date of Electronic Publication: 2023 Sep 12.
Autor:
Ducrocq Q; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France., Guédon-Moreau L; Université de Lille, Faculté de Médecine et CHU de Lille, Clinique de Cardiologie et Maladies Vasculaires, F-59000 Lille, France., Launay D; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, France.; Inserm, F-59000 Lille, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France., Terriou L; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France., Morell-Dubois S; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France., Maillard H; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France., Lefèvre G; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, France.; Inserm, F-59000 Lille, France.; CHU Lille, Laboratoire d'Immunologie, F-59000 Lille, France., Sobanski V; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, France.; Inserm, F-59000 Lille, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France., Lambert M; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.; Inserm, F-59000 Lille, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France.; CHU Lille, Département de Médecine Polyvalente Post-Urgences, F-59000 Lille, France.; Univ. Lille, U1167-RIDAGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, F-59000 Lille, France., Yelnik C; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.; Inserm, F-59000 Lille, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France.; CHU Lille, Département de Médecine Polyvalente Post-Urgences, F-59000 Lille, France.; Univ. Lille, U1167-RIDAGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, F-59000 Lille, France., Farhat MM; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France., Garcia Fernandez MJ; Unité Matériaux et Transformations (UMET) UMR CNRS 8207, Université Lille 1, F-59655 Villeneuve d'Ascq, France.; Inserm, CHU Lille, U1008-Controlled Drug Delivery System and Biomaterials, University Lille, F-59000 Lille, France., Hachulla E; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, France.; Inserm, F-59000 Lille, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France., Sanges S; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, France.; Inserm, F-59000 Lille, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France.
Publikováno v:
Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2023 Aug 31; Vol. 11 (17). Date of Electronic Publication: 2023 Aug 31.
Autor:
Penet T; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France., Pokeerbux MR; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France., Morell-Dubois S; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France., Sanges S; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France., Maillard H; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France., Ledoult E; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France., Lambert M; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France., Yelnik C; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France., Sobanski V; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France., Launay D; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France., Hachulla E; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France., Farhat MM; University Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France; Inserm, 59000 Lille, France; Service de médecine interne et immunologie clinique, CHU de Lille, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), 59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, France. Electronic address: meryemmaud@hotmail.fr.
Publikováno v:
La Revue de medecine interne [Rev Med Interne] 2023 Aug; Vol. 44 (8), pp. 394-401. Date of Electronic Publication: 2023 Apr 21.
Autor:
Astouati Q; CHU Lille, Département de Médecine Interne et Immunologie Clinique, F-59000 Lille, France; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France., Provot F; CHU de Lille, Nephrology, Dialysis and Transplantation Department, 59000 Lille, France., Farhat MM; CHU Lille, Département de Médecine Interne et Immunologie Clinique, F-59000 Lille, France; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France., Launay D; CHU Lille, Département de Médecine Interne et Immunologie Clinique, F-59000 Lille, France; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France; Univ. Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France; INSERM, F-59000 Lille, France., Sanges S; CHU Lille, Département de Médecine Interne et Immunologie Clinique, F-59000 Lille, France; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000 Lille, France; Univ. Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France; INSERM, F-59000 Lille, France. Electronic address: sebastien.sanges@univ-lille.fr.
Publikováno v:
Joint bone spine [Joint Bone Spine] 2023 Mar; Vol. 90 (2), pp. 105522. Date of Electronic Publication: 2023 Jan 07.